Download presentation
Presentation is loading. Please wait.
Published byDana Dickerson Modified over 9 years ago
1
Ankita Desai HUMAN AFRICAN TRYPANOSOMIASIS (SLEEPING SICKNESS)
2
Disease2007 US$2008 US$2008 Nominal US$2007%2008% 2007 Rank 2008 Rank HIV/AIDS1,083,018,1931,164,882,5511,215,841,70842.339.411 Malaria468,449,438541,746,356565,985,82718.3 22 Tuberculosis410,428,697445,927,582467,538,63516.015.133 Kinetoplastids125,122,839139,207,962145,676,5174.94.744
3
Kinetoplastids include Sleeping sickness. Approximately 400 million people are at risk of contracting a kinetoplastid disease.
4
Distribution of funds for sleeping sickness
5
Human African Trypanosomiasis = “sleeping sickness” Early stage vs. late stage WHAT IS HAT?
6
Tsetse fly is a vector HOW DOES ONE CONTRACT HAT?
7
Trypanosoma brucei gambiense – chronic Trypanosoma brucei rhodesiense – acute; infects cattle and humans WHAT CAUSES DISEASE?
8
Nucleus Kinetoplast (circular DNA inside mitochondrion) Flagella for movement STRUCTURE OF TRYPANOSOME
9
TRANSMISSION/THE PARASITE’S LIFE CYCLE
10
36 African countries & ~ 60 million people at risk in 1996. WHO estimate: b/w 50,000 and 70,000 people are infected. WHO DOES IT AFFECT?
11
HAT mainly affects the most productive age group (15 to 45 years). At risk if near/on: forest trails water collection points in forests Riverbanks forest edges surrounding plantations Flies are attracted by large moving objects and by CO 2 which is why they often feed on animals and humans WHO IS MOST SUSCEPTIBLE?
12
Look for inflammation of the brain and its covering, the meninges Tests include the following: Blood smear Cerebrospinal fluid tests Complete blood count (CBC) Lymph node aspiration HOW TO DETECT HAT
13
drug treatment Melarsoprol Eflornithine (T. gambiense only) Nifurtimox (used with Eflornithine) HOW CAN WE CURE INFECTED PERSONS?
14
PROBLEM OF RELAPSE AND POTENTIAL DRUG RESISTANCE Year Total NorthernCentralSouthern No. treated No. (%) relapsed No. treated No. (%) relapsed No. treated No. (%) relapsed No. treated No. (%) relapsed 200170890 (12.7)1,154284 (24.6)50646 (9.1)2,368420 (17.7) 200257256 (9.8)799180 (22.5)13536 (26.7)1,506272 (18.1) 200336257 (15.7)570171 (30.0)11939 (32.8)1,051267 (25.4) Total1,642203 (12.4)2,523635 (25.2)760121 (15.9)4,925959 (19.5) Melarsoprol relapse rates in second-stage human African trypanosomiasis patients, Equateur Nord Province, 2001–2003
15
WHO suggests supplying people with tsetse fly traps HOW CAN THE DISEASE BE PREVENTED?
16
QUESTIONS?
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.